XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,305,116 | +24.7% | 126,028 | +40.5% | 0.01% | -15.4% |
| Q2 2023 | $3,453,604 | -8.4% | 89,704 | -14.8% | 0.01% | -76.8% |
| Q1 2023 | $3,769,832 | +10.5% | 105,332 | +21.7% | 0.06% | -9.7% |
| Q4 2022 | $3,411,365 | +7.4% | 86,517 | -1.7% | 0.06% | +1.6% |
| Q3 2022 | $3,176,000 | -35.5% | 87,971 | -45.7% | 0.06% | -55.1% |
| Q2 2022 | $4,926,000 | +4.4% | 161,927 | +4.9% | 0.14% | +7.9% |
| Q1 2022 | $4,717,000 | +109.7% | 154,308 | +114.4% | 0.13% | +80.0% |
| Q4 2021 | $2,249,000 | +2126.7% | 71,984 | +841.3% | 0.07% | +48.9% |
| Q3 2018 | $101,000 | – | 7,647 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |